Skip to main content
. Author manuscript; available in PMC: 2009 Jul 26.
Published in final edited form as: Vaccine. 2008 Mar 28;26(20):2528–2536. doi: 10.1016/j.vaccine.2008.03.004

Table 1.

Demographic characteristic by focus group topic

Characteristic Willingness to participate in an HIV vaccine triala (n = 58) N (%) HIV vaccine acceptabilitya (n = 99) N (%)
Age (mean)b 36.3 33.0
Race/ethnicityb
 Black/African American 20 (35) 20 (22)
 Hispanic/Latino 32 (56) 39 (44)
 White 3 (5) 25 (28)
 APIc, Native American, other 2 (4) 5 (6)
Gender
 Male 36 (63) 52 (53)
 Female 21 (37) 47 (47)
Sexual orientationb
 Heterosexual 23 (40) 38 (43)
 Gay/Lesbian 21 (37) 27 (30)
 Bisexual 2 (4) 18 (20)
 Refuse to answer 11 (19) 6 (7)
Relationship status
 Single 41 (72) 61 (69)
 Partnered/Married 10 (18) 20 (22)
 Divorced 4 (7) 3 (3)
 Widowed 2 (3) 0 (0)
 Refuse to answer 0 (0) 5 (6)
Employment
 Full-time 19 (33) 26 (29)
 Part-time 6 (11) 14 (16)
 Unemployed 31 (54) 45 (51)
 Refuse to answer 1 (2) 4 (4)
Annual income ($)
 0-10,000 33 (58) 42 (47)
 10,001-20,000 10 (18) 15 (17)
 20,001-30,000 3 (5) 7 (8)
 >30,000 4 (7) 9 (10)
 Refuse to answer 7 (12) 16 (18)
Health insurance
 Health insurance 24 (42) 44 (49)
 No health insurance 30 (53) 45 (51)
 Refuse to answer 3 (5) 0 (0)
a

One participant in the willingness to participate focus groups and 10 in the vaccine acceptability groups did not turn in completed questionnaires.

b

p < 0.05.

c

API = Asian/Pacific Islander.